Pricing Log in Create free account
Saturday 17 October 2026 Export JNJ’s income statement to Excel — free account

Johnson & Johnson

JNJ Healthcare Drug Manufacturers General

Johnson & Johnson’s revenue for fiscal 2025 (year ended December 2025) was $94.2 billion, up 6.05% from fiscal 2024. In the quarter to September 2026, revenue grew 5.86%, EPS was flat, free cash flow grew 154.8% and total debt fell 4.82%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for three, operating cash flow growth for three; insiders bought in the last twelve months.

255.55 2.27 +0.90%
Market cap
$610.4B
P/E
29.6×
Fwd P/E
24.9×
Dividend yield
2.07%
F-score
3/9
Altman Z
4.78
Beneish M
−2.26
Dividend safety
78/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Johnson & Johnson (JNJ) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Johnson & Johnson (JNJ) trades at a P/E ratio of 29.6×. Over the past ten years it has ranged from 9.5× (May 2024) to 380× (January 2018); the current reading is higher than 84% of that period. That is above the Drug Manufacturers General industry median of 24.5× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 18.7× (24.87%)
FY2024 24.9× 115.20%
FY2023 11.6× (56.19%)
FY2022 26.4× 20.70%
FY2021 21.9× (23.31%)
FY2020 28.6× 10.34%
FY2019 25.9× 12.53%
FY2018 23.0× (93.56%)
FY2017 357× 1,712.12%
FY2016 19.7× 5.29%

Quarterly newest first

Period P/E ratio Change
Sep 2026 30.7× 4.24%
Jun 2026 29.4× 4.14%
Mar 2026 28.3× 50.89%
Dec 2025 18.7× 4.64%
43 more quarters

Against its own ten years

Low 9.5× High 380×
Ten-year median 23.4×
Current reading's percentile 83

P/E ratio against peers

Company P/E ratio
GILD Gilead Sciences, Inc. compare n/m
NVS Novartis AG compare 22.6×
AZN AstraZeneca PLC compare 24.5×
AMGN Amgen Inc. compare 26.7×
JNJ Johnson & Johnson 29.6×
PFE Pfizer Inc. compare 38.9×
LLY Eli Lilly and Company compare 42.2×
ABBV AbbVie Inc. compare 80.6×
MRK Merck & Co., Inc. compare 117×
Drug Manufacturers General industry median 24.5×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on JNJ